TL; DR

• Launchpad V2: Low-cap sales for BioAgents, BioDAOs, and IP-Tokens.
• BioXP System: Earn points via staking, governance, and social engagement. Points determine access to new token launches.
• Staking BIO & Ecosystem Tokens: Stake BIO and ecosystem tokens (BioAgents, BioDAOs, and IP-Tokens) to earn BioXP.

Background & Motivation

The first version of the launchpad focused on large, one-time fundraising events. While that approach helped bootstrap initial projects, it often resulted in unrealistic valuations, misaligned incentives, and low long-term community engagement.

Motivated by these insights, Bio Protocol V2 introduces:

• Smaller, Ongoing Funding: Funding shifts from large, one-off sales to smaller, incremental raises that grow with community traction and scientific progress.
• Stronger Community Ties: Sale allocations require BioXP, aligning token distribution with active ecosystem contribution.
• Automation with Agentic AI: Integrate AI-driven agents (BioAgents) to lower overhead and create automated research loops.
• Long-Term Alignment: Encourage holding and participating through rewards (points, staking yields, governance power) and disincentivize short-term flipping.

In summary, Bio Protocol V2 aims to increase velocity and sustainability: enabling rapid launches of experimental projects with minimal initial capital, while providing tools for those projects to continuously fund themselves through market activity.

Proposal Details

Note: Initial deployment of Bio V2 will be on the Base L2 blockchain, with Solana deployments launching soon. Meaning, users will need to bridge their BIO tokens to Base, or purchase BIO on Base, in order to participate in the new system.

1. Launchpad V2

Bio Protocol will introduce a new launchpad for new BioAgents, BioDAOs, IP-Tokens in a single unified platform.

Key launch mechanics:

• Ignition Sales: Each Ignition sale sets a predetermined token price and a modest raise cap. All participants who secure an allocation pay the same price per token.
  • For example, initial BioAgent launches will target a raise goal of $77K (in BIO) for 37.5% of the initial supply, valuing the project at ~$205k FDV. If the goal isn’t met within the sale duration (set to 2-3 days for initial sales), funds are returned.
• Denomination in $BIO: Participants must commit BIO tokens to join the sale.
• BioXP Pledging: Participants pledge BioXP (Bio Experiment Points) to vie for an allocation in the sale.
  • Each user’s allocation = (User’s pledged BioXP / Total BioXP pledged by all users) * Total tokens available in sale.
• Individual Allocation Cap: To ensure broad participation, each user is limited to purchasing at most 0.5% of the total token supply in the sale.
• Liquidity Engine: 100% of raised funds (BIO tokens) seed the project’s liquidity pool, paired with 12.5% of token supply. Token trades incur 1% fee: 70% to project for research funding, 30% to Bio Protocol. For initial BioAgent launches, the token can list on the AMM at an implied FDV of $615K (3X the sale FDV).
• Sample Allocation: Projects may use a template (e.g., 37.5% Sale, 12.5% LP, 18% Treasury, 10% Team, 20% DAO, 2% Bio Protocol) or adjust as needed.

Full details on the Launchpad in the Bio V2 Docs.

2. BioXP – Points-Based Engagement Layer

BioXP is a new points-based reward system introduced in Bio Protocol V2. It is not a transferable token, but rather a reputation/loyalty point that is earned through positive-sum activities in the Bio ecosystem.

• Earn Points by:
  • Staking BIO or Ecosystem Tokens (IP-Tokens, BioAgent or BioDAO tokens)
  • Participating in governance
  • Yapping on social media (via connected X account)
• Using BioXP in Launches: To participate in a project’s Ignition sale, users must pledge BioXP and commit BIO tokens. The share of points you contribute (relative to all participants’ points) determines the fraction of the sale you can buy (up to the per-user cap). Any unused BIO and BioXP are returned to you.
• Incentive to Hold: If a user receives an allocation in an Ignition sale and sells those new tokens within the first three weeks of trading, the user’s ability to earn new BioXP is paused for the next 21 days. This doesn’t remove your existing points, but it means you can’t farm points during the paused period.
• Point Expiration: Unused points expire after 14 days to keep the system dynamic. Note: Retroactive BioXP (explained below) will only begin to expire one month after the first launch.
• Retroactive BioXP: To reward those who have been supporting Bio and DeSci for a while, a one-time retroactive distribution of BioXP is awarded to past contributors. 50% of the initial BioXP pool will be awarded retroactively across the following categories:
  • Early Auction Participants (50% of retro pool): Everyone who participated in Bio V1 auctions: Quantum Biology DAO, Long Covid Labs, Curetopia, MycoDAO and SpineDAO. Higher participation correlates with more points.
  • Curators (20%): Users who actively curated BioDAOs in Bio V1.
  • Governance Participants (10%): Users who participated in Governance Across the DeSci Ecosystem
  • BIO Genesis Auction Participants (20%): Addresses that took part in the very first BIO Genesis sale in 2024.

Full details on BioXP Mechanics & Distribution in the Bio V2 Docs

3. Staking $BIO and Ecosystem Tokens (veBIO Mechanism)

Staking is a cornerstone of Bio Protocol V2, serving two purposes: governance power and BioXP generation. Bio V2 introduces two staking systems:

• Staking BIO (to get veBIO): Inspired by Curve’s veCRV model, users can stake BIO to receive veBIO (vote-escrowed BIO). BIO stakers receive governance power while earning BioXP.
• Ecosystem Token Staking: To further integrate the ecosystem, users can stake Bio ecosystem project tokens (BioAgents, BioDAO tokens, IP-Tokens) to earn BioXP.

More details:

Staking BIO for veBIO:

• Lock Duration: Lock from 2 weeks to 2 years. Longer locks give more veBIO. veBIO awarded = BIO staked * (lock_duration_in_weeks / 104).
• Linear Decay: As time passes, your veBIO balance decreases linearly until your lock expires, ensuring that active, long-term commitments hold the most voting power at any given time.
• Auto-Renewal Option: To avoid the hassle of re-locking and to maintain voting power, stakers can enable auto-renewal. If turned on, when your lock would expire, it automatically resets to your originally chosen duration. Note: Active auto-renewal also means veBIO does not decay. In the moment that auto-renewal is turned off, the decay for the lock time starts and runs for the period of time the lock was set.
• No Early Exit: BIO staked for veBIO cannot be unlocked early.
• Governance Power: Once veBIO gains sufficient adoption, a governance vote can take place to switch voting in BIO and vBIO to veBIO. If approved, veBIO holders will govern Bio Protocol (replacing vBIO from V1 as the source of voting power). 1 veBIO will equal 1 vote in DAO proposals. This means long-term stakers have more say in decisions. Note: vBIO (vesting BIO) from V1 remains separate – it continues to vest into liquid BIO for those who have it, but once the switch is made, vBIO will no longer confer governance power in V2.

Staking Ecosystem Tokens:

• Users can stake Bio ecosystem project tokens (BioAgents, BioDAO tokens, IP-Tokens) to earn BioXP.
• No fixed lock; 14-day withdrawal cooldown.
• Earn BioXP pro-rata to stake size.

Full details on Staking & veBIO in the Bio V2 Docs

4. Implementation Plan

• Contracts audited pre-launch
• DAO multisig governs parameters (emissions, fees)
• Bio App upgrades:
  • Launchpad UI
  • BioXP dashboard
  • Staking interface
  • Wallet/social linking
  • Portfolio tracker
• Retroactive BioXP drop claimable in the Bio App

Timeline

• July 31: Retroactive BioXP claimable in the Bio App & BioXP earning commences
• Early August: First BioAgent launch on Base
• August-September: Continuous roll-out of new BioAgents, BioDAOs and IP-Tokens
• September+: Expansion to Solana

5. Conclusion

This next phase of Bio is about velocity and continuous innovation: enabling rapid, experimental launches and giving users new ways to engage and earn, ultimately accelerating breakthroughs onchain.